Browse Guides  internal medicine  gastroenterology

Inflammatory bowel disease

Prevalence
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Therapy

Give patients with distal ulcerative colitis rectal a and oral 5-aminosalicylate a

Why?

  • Rectal aminosalicylates lead to more remission than low-dose rectal steroids or rectal budesonide, but are not clearly better than high-dose rectal steroids a
  • Combining rectal and oral aminosalicylates stops rectal bleeding in more patients and sooner (on average by 13 days) than either alone a

Ulcerative colitis: combining oral and rectal mesalamine stops rectal bleeding better than either alone

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
distal ulcerative colitis a daily oral mesalamine and twice weekly rectal mesalamine oral or rectal mesalamine cessation of rectal bleeding
at 6 weeks
60% 40%
(1% to 96%)
4
(2 to 88)

Ulcerative colitis: rectal 5-ASA is more effective than low-dose rectal steroids at inducing remission

Patient Treatment Comparison Outcome CER OR
(95% CI)
NNT
(95% CI)
distal ulcerative colitis a low-dose rectal corticosteroids rectal 5-ASA symptomatic remission
at 2-7 weeks
9% 2.42
(1.72 to 3.41)
-10
(-18 to -6)
  rectal 5-ASA budesonide symptomatic remission
at 4 weeks
9% 0.41
(0.18 to 0.94)
20
(14 to 200)

Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   L   Friedman
CAT Writers   D   Ford , CM   Ball